Lynparza 150mg Tablet (Olaparib)

Lynparza 150mg Tablets is a prescription-based anticancer medicine used in the treatment of pancreatic, breast, prostate and ovarian cancer. The active ingredient of this tablet is olaparib, which belongs to the drug class of poly-adenosine diphosphate-ribose polymerase (PARP) inhibitors. Lynparza (Olaparib) works by blocking enzymes PARP proteins that repair damaged DNA, which kill specific types of cancer cells, resulting in controlled disease progression. It is usually given in combination with another anticancer medicine as a part of combination therapy to increase the efficacy of the treatment.

The tablet must be taken orally and swallowed whole with water and should not be crushed, chewed, or opened. The prescribed dose and duration of the Olaparib 150mg tablet depend on the patient's condition and response to treatment. It can also be taken with or without food. Patients are advised not to change the dosage and timings prescribed by the doctors because it can cause severe side effects.

Common side effects include nausea, vomiting, diarrhea, indigestion, tiredness, weakness, headache, dizziness, decreased appetite, and changes in blood cell counts. Most of the Olaparib 150mg tablet side effects can leave when the body adapts to the medicine. However, report to your doctor if you experience serious side effects.

Pregnancy should be avoided during treatment, as the medicine can cause fetal harm. Women who are breastfeeding should consult with their doctor before the therapy. Patients must list all medicines, supplements, and herbal products that they are taking. The Olaparib 150mg tablet must be used under medical oversight or medical supervision only. Attend regular tests and follow-ups to monitor the medicine response and reduce side effects. Before making any adjustments, changing the dose, or stopping the treatment, consult with your doctor to maximize the benefit.

​Breast Cancer​

The human body shows undesired symptoms after taking Olaparib 150mg Tablets (Lynparza). Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Some of the common side effects of Lynparza Tablets (Olaparib) are mentioned below:
● Cough
● Anemia
● Nausea
● Fatigue
● Diarrhea
● Vomiting
● Headache
● Indigestion
● Breathlessness
● Loss of appetite
● Abdominal pain
● Change in taste
● Decreased blood cells (RBC, WBC, and platelets)

Olaparib 150mg Tablets (Lynparza) is a prescription-based anticancer drug that should be administered orally. It is advised to take this tablet after consulting your healthcare expert. This tablet should be swallowed as a whole with water. Don't crush, chew, or break it. It can be taken with or without food. Never skip a dose or double dose.

● Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., ... & Kindler, H. L. (2019). Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. New England Journal of Medicine, 381(4), 317-327.
● Moore, K., Colombo, N., Scambia, G., Kim, B. G., Oaknin, A., Friedlander, M., ... & DiSilvestro, P. (2018). Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. New England Journal of Medicine, 379(26), 2495-2505.
● Mateo, J., Carreira, S., Sandhu, S., Miranda, S., Mossop, H., Perez-Lopez, R., ... & de Bono, J. S. (2015). DNA-repair defects and olaparib in metastatic prostate cancer. New England Journal of Medicine, 373(18), 1697-1708.
● Robson, M., Im, S. A., Senkus, E., Xu, B., Domchek, S. M., Masuda, N., ... & Conte, P. (2017). Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. New England Journal of Medicine, 377(6), 523-533.
● Deeks, E. D. (2015). Olaparib: first global approval. Drugs, 75(2), 231-240